Category: Wall Street Beat
Royal Philips deals an 80% stake in its lighting components business to Go Scale Capital for $nearly $3 billion.
Olympus says it agreed to pay $92 million to settle a pair of civil lawsuits brought over the 2001 accounting scandal that nearly brought the company down.
Johnson & Johnson inks a deal with Google to develop a robot-assisted surgery device.
ReWalk Robotics plans to launch its wearable robotic exoskeleton device in India by the 2nd quarter.
(Reuters) — ReWalk Robotics (NSDQ:RWLK) plans to launch its wearable robotic exoskeleton in India by the 2nd quarter, CEO Larry Jasinski said.
Here's a look at some of the top Wall Street stories for medical device companies this week: Boston Scientific's gain is St. Jude Medical's loss; Abiomed soars to new all-time high on FDA nod; Philips mulls 2016 IPO for lighting biz as bidding war heats up; SteadyMed prices $40m IPO well under range; Becton Dickinson to shed assets after CareFusion buy
, Bain Capital
, Becton Dickinson & Co.
, Boston Scientific
, CareFusion Corp.
, CVC Capital Partners
, Food & Drug Administration (FDA)
, GSR Ventures
, Kohlberg Kravis Roberts & Co. L.P.
, Lattice Power
, Royal Philips
, St. Jude Medical
, SteadyMed Therapeutics
, Abiomed Inc.
, Allergan Inc.
Valeritas delays an initial public offering that would have brought in $75 million at the midpoint.
Valeritas today postponed its planned initial public offering, which at the midpoint was slated to fetch $75 million for its V-Go basal insulin delivery system for Type II diabetes, Renaissance Capital reported.
Earlier this month Valeritas said it planned to put up 5 million shares at $14 to $16 each.
Becton Dickinson is reportedly planning to shed its respiratory devices business now that it's closed its $12.4 billion acquisition of CareFusion.